The HBOT–ACNU treatment induced molecular regulation network combined with KEGG database data, using Pathway Builder software, as were illustrated in Figure 5, showing that HBO increased the sensitivity of ACNU against glioma by regulating HIF–TNF–NF‐κB signaling pathway. This evidence concerns the gene NFKB1 and glioma.